Revive Therapeutics (RVVTF, RVV): Updates and News Archive.
Recent Headlines
(See FDA Filing Submission at Bottom)
LIVE QUOTE
ABVC BioPharma (ABVC) Approved for ABV-1505 Phase II Part II in Taiwan Sites
Gentleman, Start Your Engines?
ABVC BioPharma Receives Taiwan Regulatory Approval for ABV-1505 ADHD Phase II Part 2 Clinical Study
GeoVax (GOVX) Research Reports Archive
Research Report Archive
Reports from Robert LeBoyer at Noble Capital. Jeffrey Kraws and Karen Goldfarb at Crystal Research....
Committed to Win. C-1 and Dyadic’s (DYAI) Drive to Make Vaccines Affordable Worldwide.
Dyadic International, Inc. (NASDAQ: DYAI) – We are a global biotechnology company focused on further improving and leveraging the patented and proprietary...
Does Co-Diagnostics (CODX) Have Ties to Offshore Boiler Rooms?
Hot Covid-19 test company has ties to offshore boiler rooms (SharesSleuth.com)
AKA, you'd have to have your head examined...
It’s Biotech Season! Five Deals to Raise $611 Million.
The Biotech IPO Queue Grows Longer as Five More Companies File (Xconomy)
Alkero Therapeutics, $86 Million.Prevail Therapeutics, $100...
TeleHealths’ Screaming Growth in Canada.
"Dialogue says it has also seen a surge of customer interest, with 100 companies subscribing to its annual service in the past...
Revive (RVVTF) Hits a Snag?
Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19
First our summary."FDA provided communication that...
Where is Citius Pharma (CTXR) in the FDA Approval Process?
We have a number of subscribers asking for an update on the FDA approval process for Mino-Lok. In layman's term (assuming approval)...
Corona Craziness Continues. Immuron (IMRN) Gains 10-Fold or 1000%, in 3 Months!
Too bad we don’t trade for a living! We don’t even use real-time quotes, LOL. $2.57 to $27.13, from March 3rd ...
Latest article
Ardelyx (ARDX) Reports First Quarter 2024 Showing $204 Million in Cash!
When we added Ardelyx (ARDX) to the Watch List in November of 2022, the market cap near $80 million. Now it's...
GeoVax to Provide Corporate Update on Tuesday May 14, 2024.
Still our favorite biotech microcap, still our favorite management team, and our favorite risk to reward idea with a $4 million market...
NovaVax (NVAX) Roars Higher, Gaining 225% a $1.2 Billion Increase, at the Blink of...
Sanofi (SNY) Announces Partnership - $500 Million Upfront, plus $700 million in Milestones with NovaVax (NVAX). And some investors say Covid is...
